Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Ladies and Gentlemen, the science is in. The answer to whether or not vitamin D3 supplementation prevents multiple myeloma (MM) is…
“highly convincing evidence of a clear role of vitamin D does not exist for any outcome.”
What does that mean? Why do studies have to be so confusing???PeopleBeatingCancer is built on “evidence-based research.” Does supplementing with vitamin D3 prevent cancer or not?!
The three studies linked and excerpted below basically say that the evidence is vague. Science often is. But the studies conclude that vitamin D3 supplementation probably reduces cancer in general and multiple myeloma in particular.
I’m a long-term MM survivor who must decide for himself what the studies point to. I live in Cleveland, Ohio (think lots of clouds and very little sunshine…). I have sustained chemotherapy induced heart, brain and nerve damage in addition to being at increased risk for many different cancers.
I have a blood test annually to keep track of my serum blood levels of vitamin D.
I supplement with vitamin D3 daily- (2 x 1000 mg.) Life Extension Foundation Vitamin D3. I think you should too. Vitamin D3 supplementation has been shown to reduce the risk of a host of chronic diseases. LE Vitamin D3 has been tested and approved by ConsumerLab.com, an independent testing agency. Vitamin D3 is the cheapest cancer treatment you will ever see.
For more information about nutritional supplementation to reduce the risk of cancer or a relapse of cancer, scroll down the page, post a question and I will reply ASAP. Thank you,
“Here, we studied 83 unselected multiple myeloma patients from December 2007 through December 2014. Lower 25(OH) D levels (<10 ng/mL) were associated with higher number of plasma cells in the bone marrow.
Supplementation of vitamin D was accompanied with a significant increase in:
while thrombocytes (200.5 to 175.2 p = .036) decreased.
In conclusion, the present study found a high incidence of vitamin D deficiency and insufficiency in MM patients. In myeloma patients, vitamin D levels and supplementation should be more widely taken into account.”
“There is a debate about whether sufficient doses can be obtained through diet alone. The exact amount needed is hard to define and depends on factors like age, body weight, and where people live. Vitamin D status can be determined by the measurement of serum 25-hydroxyvitamin D, although optimal vitamin D levels are controversial.…
Two recent Cochrane Reviews by Bjelakovic and colleagues have addressed hot topics in vitamin D supplementation. The first review, from January 2014, analysed 38 randomised controlled trials (RCTs) with 76,627 participants in high-income countries and showed that vitamin D3 reduced all-cause mortality in adults (mostly elderly and mostly women). About 150 people had to be treated over five years to prevent one additional death. However, combination with calcium increased the risk of renal stone formation…
A new Cochrane Review investigates whether vitamin D supplementation prevents cancer in adults.…The same results applied to participants with vitamin D status below 20 ng/mL (defined as vitamin D deficiency) and those with higher vitamin D status at entry. However, cancer mortality was lower following vitamin D3 supplementation, although the overall quality of the evidence was low…
“Conclusions Despite a few hundred systematic reviews and meta-analyses, highly convincing evidence of a clear role of vitamin D does not exist for any outcome, but associations with a selection of outcomes are probable.”